Use of antiinfective drugs in paediatric departments in health region 2;Forbruk av antiinfeksiose legemidler ved barneavdelingene i helseregion 2

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 18, 1999, Pages 2640-2644

  Westergren, Tone ^a   Abrahamsen, Tore G ^a   Egeland, Thore ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; VANCOMYCIN;

ARTICLE; DRUG COST; DRUG RESISTANCE; DRUG USE; HOSPITAL PHARMACY; HUMAN; NORWAY; PEDIATRICS; ANTIBIOTIC RESISTANCE; CHILD; DRUG UTILIZATION; ECONOMICS; HOSPITAL; INTENSIVE CARE; LENGTH OF STAY; PRACTICE GUIDELINE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CEPHALOSPORINS; CHILD; DRUG COSTS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; GUIDELINES; HOSPITALS, PEDIATRIC; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; NORWAY;

EID: 0033543078     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nyquist A-C, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 1998; 279: 875-7.
2. Abrahamsen TG, Alsaker T, Fjærli H-O, Flægstad T. Diagnostikk og behandling av infeksjoner hos barn. 2. utg. Oslo: Norsk barnelegeforening, 1994.
3. Straand J, Rokstad K, Heggedal U. Drug pre-scribing for children in general practice. A report from the Møre & Romsdal Prescription Study. Acta Paediatr 1998; 87: 218-24.
4. Midtvedt T. Mikrobiologi og økologi - mikrobeaspektet. Tidsskr Nor Lægeforen 1995; 115: 2896-8.
5. Hanberger H, Nilsson LE. Ḧg antibiotikaresistens inom svensk intensivvård. Läkartidningen 1997; 94: 2381-6.
6. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 1996; 275: 234-40.
7. Struelens MJ. The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions. BMJ 1998; 317: 652-4.
8. Turnidge J. What can be done about resistance to antibiotics? BMJ 1998; 317: 645-7.
9. Legemiddelforbruket i Norge 1993-1997. Oslo: Norsk Medisinaldepot, 1997.
10. Menczel E, Hershkowitz A, Levy D, Akivison L, Boldur I. Inpatient antimicrobial use in two hospitals near Tel Aviv. Am J Hosp Pharm 1992; 49: 659-63.
11. Lew DP, Garbino J, Gerber AU, Sudre P and the Swiss Committee of Anti-Infective Agents. Use of antimicrobials in Swiss hospitals. Drugs 1996; 52 (suppl 2): 88-91.
12. Kennedy DL, Forbes MB, Baum C, Jones JK. Antibiotic use in U.S. hospitals in 1981. Am J Hosp Pharm 1983; 40: 797-801.
13. Kappstein I, Daschner FD. Antibiotic usage in community-acquired pneumonia: results of a survey in 288 departments of internal medicine in German hospitals. Infection 1991; 19: 301-4.
14. Guglielmo L, Leone R, Moretti U, Conforti A, Spolaor A, Velo G. Antibiotic prescribing patterns in Italian hospital patients with pneumonia, chronic obstructive pulmonary disease and urinary tract infections. Ann Pharmacother 1993; 27: 18-22.
15. Berild D. Er det mulig å påvirke bruken av antibiotika? Tidsskr Nor Lægeforen 1997; 117: 2056-9.
16. Andrew M, Solberg CO. Forbruket av antimikrobielle midler i Norge i 1980-92. Tidsskr Nor Lægeforen 1994; 114: 169-73.
17. Jarvis WR. Epidemiology, appropriateness and cost of vancomycin use. Clin Infect Dis 1998; 26: 1200-3.
18. Fraser GL, Stogsdill P, Dickens JD, Wennberg DE, Smith RP, Prato S. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 1997; 157: 1689-94.
19. SAS/STAT Software: changes and enhancements through release 6.11. Cary, NC: SAS Institute, 1996: 1104.
20. Larsen RA, Curtis ET, Jacobson JA, Burke JP. Trends in infections and antibiotic usage in a community hospital. Am J Infect Control 1987; 15: 7-15.
21. Leigh DA. Antimicrobial usage in forty-three hospitals in England. J Antimicr Chemother 1982; 9: 75-84.
22. Shapiro M, Townsend TR, Rosner B, Kass EH. Use of antimicrobial drugs in general hospitals. Patterns of prophylaxis. N Engl J Med 1979; 301: 351-5.
23. Grasela TH, Welage LS, Walawander CA, Timm EG, Pelter MA, Poirier T et al. A nation-wide survey of antibiotic prescribing patterns and clinical outcomes in patients with bacterial pneumonia. Ann Pharmacother 1990; 24: 1220-5.
24. McElnay JC, Scott MG, Sidara JY, Kearney P. Audit of antibiotic usage in a medium-sized hospital over an 11-year period. Pharm World Sci 1995; 17: 207-13.
25. Natsch S, Hekster YA, de Jong R, Heerdink ER, Herings RMC, van der Meer JWM. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis 1998; 17: 20-4.